Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Hematologic Disorder. Data from NIH RePORTER, last 36 months.
Hematologic Disorder has active NIH research funding with 8 funded grants totaling $4.4M.
4 new grants started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Hematologic Disorder. Strongest funded area: Basic Science. Largest gap: Clinical Research.
3 clinical trials registered but no NIH-funded clinical or translational research grants found for hematologic disorder. Trials may be industry-sponsored or funded through non-NIH sources.
7 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for hematologic disorder. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Hematologic Disorder as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.